Compositions for cancer treatment using pd-1 axis binding antagonists and MEK inhibitors

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG

发明人:

JUNTTILA, Melissa

申请号：

ES15747647

公开号：

ES2742500T8

申请日:

2015.07.15

申请国别(地区):

ES

年份:

2020

代理人:

摘要：

The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/